
Biocodex is a French family-owned pharmaceutical company headquartered in Gentilly, near Paris, France. The company was founded in 1953 to develop and market the world’s first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®, discovered in 1923.
Building on relationships established for nearly 70 years with healthcare professionals, the Biocodex teams work daily for the health of all and focus their activities around three main areas: Microbiota, Orphan diseases, Women’s health
With more than 1,800 employees, Biocodex generated net revenues of above €634 million in 2024, including 32% in France and 68% internationally. The group is present in more than 100 countries through wholly owned subsidiaries in 17 countries and a network of distributors worldwide.
The Global Business Development Analyst will be part of the Global Business Development within Biocodex and will report into the Chief Business Development Officer (CBDO) – Global Business Development.
The Global Business Development Analyst will support the CBDO to enable and facilitate business processes and decisions to become best operational practice at BIOCODEX. He will improve our dashboards/database, help coordinate and prepare for key internal and external meetings as well as partnering conferences. He will also participate on teams evaluating Business Development opportunities. This role includes collaboration with stakeholder functions within BIOCODEX such as R&D, Operations, Orphan Division, Finance, HR, Customer Experience & Legal.
OTHERS INFORMATIONS
Type of contract : permanent contract (CDI)
Location : Gentilly (accessible ligne 4, Rer B, Tram T3a)
Desired start date: as soon as possible
Benefits: Personal/Personal Benefits, remote work, transportation costs (70%), social work, etc.
Position open to people with disabilities
Our four values are driving forces and bonds for all teams: we play collectively; we shape fair relations; we dare to innovate; we care for our ecosystem.
At Biocodex, we do not discriminate on the basis of gender, age, disability, nationality or sexual orientation. In fact, we welcome diversity, which we recognize as a source of strength for the company.
At Biocodex, our CSR approach is an holistic one to reconcile the « 4P’s »: « People, Planet, Profit and Purpose » and we also ensure that our employees are provided with necessary and relevant tools for both their personal and professional development, while offering them competitive advantages and services.
Join us!
Biocodex HQ
Siège Gentilly
Take up the challenge and send your application!

Biocodex is a French pharmaceutical company founded in 1953 to develop and market the world’s first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Today, Biocodex focuses its business on three main areas: Microbiota care; Women’s health; Orphan diseases. With more than 1,700 employees, Biocodex generated net revenues of above €500 million in 2023, including 1/3 in France and 2/3 internationally. The group is present in more than 100 countries through wholly owned subsidiaries in 16 countries and a network of distributors worldwide.
To report quality complaint(s) or adverse event(s) related to Biocodex products please visit https://www.biocoreport.com/en/